PDSB PEER ANALYSIS

PDS Biotechnology Corp — metric-by-metric comparison with peers and the industry median

PDSBPDS Biotechnology Corp

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

PDSBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PDSB	RTALB	MSB	Ind. Median
P/E	—	4.89	—	17.81
P/B	12.06	0.61●	—	3.49
EV/EBITDA	—	74.61	—	14.92
P/S	—	6.67●	31.91	10.89

Financial Health
Metric	PDSB	RTALB	MSB	Ind. Median
Current Ratio	2.26●	1.21	—	5.90
Debt/Equity	407.5%	1.2%●	—	10.9%
NetDebt/EBITDA	0.21●	0.90	—	1.15

Profitability
Metric	PDSB	RTALB	MSB	Ind. Median
Net Margin	—	136.3%●	-115.3%	-125.7%
ROE	-254.1%	15.1%●	-11.3%	-47.5%
ROA	-93.1%	13.1%●	-8.6%	-35.8%
EBITDA Margin	—	9.0%●	-76.6%	-105.8%

Growth + Dividend
Metric	PDSB	RTALB	MSB	Ind. Median
Rev. Growth	-100.0%	24.0%	410.4%●	5.1%
NI Growth	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	0.2%
Payout	—	0.0%	0.0%	0.0%

Valuation
Metric	PDSB	OTLK	PMVP	VRCA	ACRV	PLRX	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	12.06	-1.25●	0.73	4.07	0.72	0.43	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	—	108.59	—	1.76●	—	—	10.89

Financial Health
Metric	PDSB	OTLK	PMVP	VRCA	ACRV	PLRX	Ind. Median
Current Ratio	2.26	0.54	11.14	2.02	8.98	16.89●	5.90
Debt/Equity	407.5%	-93.8%●	0.3%	9.0%	2.5%	17.4%	10.9%
NetDebt/EBITDA	0.21	-0.31●	1.19	1.69	1.16	1.32	1.15

Profitability
Metric	PDSB	OTLK	PMVP	VRCA	ACRV	PLRX	Ind. Median
Net Margin	—	-18,297.5%	—	-48.0%●	—	—	-125.7%
ROE	-254.1%	—	-63.2%	—	-60.4%	-53.6%●	-47.5%
ROA	-93.1%	-297.6%	-58.6%	-44.0%	-54.4%	-41.4%●	-35.8%
EBITDA Margin	—	-18,634.1%	—	-30.6%●	—	—	-105.8%

Growth + Dividend
Metric	PDSB	OTLK	PMVP	VRCA	ACRV	PLRX	Ind. Median
Rev. Growth	-100.0%	-2.1%	—	417.6%●	-100.0%	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PDSB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.